What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials

The New York Times – Business:

Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.

This post first appeared in The New York Times – Business. Read the original article.